Trials / Conditions / Stage III Prostate Adenocarcinoma AJCC v7

Stage III Prostate Adenocarcinoma AJCC v7

9 registered clinical trials studyying Stage III Prostate Adenocarcinoma AJCC v7.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Su NCT03541850	Jonsson Comprehensive Cancer Center	Phase 2
Active Not Recruiting	Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE NCT03371719	NRG Oncology	Phase 2
Completed	Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With P NCT03274687	NRG Oncology	Phase 3
Completed	Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer NCT03070886	NRG Oncology	Phase 2 / Phase 3
Completed	A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Me NCT02849990	University of Washington	Phase 2
Completed	Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery NCT02830165	Jonsson Comprehensive Cancer Center	N/A
Completed	Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide NCT02099864	OHSU Knight Cancer Institute	Phase 2
Completed	Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer NCT01787331	University of California, San Francisco	Phase 2
Completed	Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Pr NCT01409200	M.D. Anderson Cancer Center	Phase 2